401k Plan data: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN plan

KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 401k Plan overview

Plan Name	KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN
Plan identification number	001

KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Age/Service Weighted or new comparability or similar plan - Age/Service Weighted Plan: Allocations are based on age, service, or age and service. New comparability or similar plan: Allocations are based on participant classifications and a classification(s) consists entirely or predominantly of highly compensated employees; or the plan provides an additional allocation rate on compensation above a specified threshold, and the theshold or additional rate exceeds the maximum threshold or rate allowed under the permitted disparity rules of section 401(l).
Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

KLINGENSMITH DRUG, INC. has sponsored the creation of one or more 401k plans.

Company Name: KLINGENSMITH DRUG, INC.

Employer identification number (EIN): 251258407

NAIC Classification: 446110
NAIC Description: Pharmacies and Drug Stores

Form 5500 Filing Information

Submission information for form 5500 for 401k plan KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 DAVID CIPPEL DAVID CIPPEL 2018-10-15
001 2016-01-01 DAVID CIPPEL DAVID CIPPEL 2017-10-16
001 2015-01-01 DAVID CIPPEL DAVID CIPPEL 2016-10-17
001 2014-01-01 DAVID CIPPEL DAVID CIPPEL 2015-10-15
001 2013-01-01 DAVID CIPPEL DAVID CIPPEL 2014-10-13
001 2012-01-01 DAVID CIPPEL DAVID CIPPEL 2013-10-02
001 2011-01-01 JULIE ALLEN JULIE ALLEN 2012-10-12
001 2009-01-01 DAVID CIPPEL DAVID CIPPEL 2010-10-13

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	DAVID CIPPEL	DAVID CIPPEL	2018-10-15
001	2016-01-01	DAVID CIPPEL	DAVID CIPPEL	2017-10-16
001	2015-01-01	DAVID CIPPEL	DAVID CIPPEL	2016-10-17
001	2014-01-01	DAVID CIPPEL	DAVID CIPPEL	2015-10-15
001	2013-01-01	DAVID CIPPEL	DAVID CIPPEL	2014-10-13
001	2012-01-01	DAVID CIPPEL	DAVID CIPPEL	2013-10-02
001	2011-01-01	JULIE ALLEN	JULIE ALLEN	2012-10-12
001	2009-01-01	DAVID CIPPEL	DAVID CIPPEL	2010-10-13

Plan Statistics for KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN

401k plan membership statisitcs for KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN

Measure Date Value
2022: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 102
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 74
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 4
Total of all active and inactive participants 2022-01-01 78
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 78
Number of participants with account balances 2022-01-01 40
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 106
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 85
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 17
Total of all active and inactive participants 2021-01-01 102
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 102
Number of participants with account balances 2021-01-01 52
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 125
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 100
Number of other retired or separated participants entitled to future benefits 2020-01-01 16
Total of all active and inactive participants 2020-01-01 116
Total participants 2020-01-01 116
Number of participants with account balances 2020-01-01 53
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 129
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 110
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 13
Total of all active and inactive participants 2019-01-01 123
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 123
Number of participants with account balances 2019-01-01 63
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 142
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 118
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 9
Total of all active and inactive participants 2018-01-01 127
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 127
Number of participants with account balances 2018-01-01 63
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 129
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 133
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 5
Total of all active and inactive participants 2017-01-01 138
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 138
Number of participants with account balances 2017-01-01 64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 128
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 124
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 5
Total of all active and inactive participants 2016-01-01 129
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 129
Number of participants with account balances 2016-01-01 64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 341
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 338
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 23
Total of all active and inactive participants 2015-01-01 361
Total participants 2015-01-01 361
Number of participants with account balances 2015-01-01 151
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 11
2014: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 316
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 268
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 22
Total of all active and inactive participants 2014-01-01 290
Total participants 2014-01-01 290
Number of participants with account balances 2014-01-01 160
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 6
2013: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 330
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 281
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 15
Total of all active and inactive participants 2013-01-01 296
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 296
Number of participants with account balances 2013-01-01 163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 1
2012: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 350
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 274
Number of other retired or separated participants entitled to future benefits 2012-01-01 23
Total of all active and inactive participants 2012-01-01 297
Total participants 2012-01-01 297
Number of participants with account balances 2012-01-01 161
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 4
2011: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year 2011-01-01 296
Total number of active participants reported on line 7a of the Form 5500 2011-01-01 292
Number of other retired or separated participants entitled to future benefits 2011-01-01 31
Total of all active and inactive participants 2011-01-01 323
Total participants 2011-01-01 323
Number of participants with account balances 2011-01-01 171
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2011-01-01 7
2009: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 310
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 267
Number of other retired or separated participants entitled to future benefits 2009-01-01 15
Total of all active and inactive participants 2009-01-01 282
Total participants 2009-01-01 282
Number of participants with account balances 2009-01-01 186
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 12

Measure	Date	Value
2022: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	102
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	74
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	4
Total of all active and inactive participants	2022-01-01	78
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	78
Number of participants with account balances	2022-01-01	40
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	106
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	85
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	17
Total of all active and inactive participants	2021-01-01	102
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	102
Number of participants with account balances	2021-01-01	52
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	125
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	100
Number of other retired or separated participants entitled to future benefits	2020-01-01	16
Total of all active and inactive participants	2020-01-01	116
Total participants	2020-01-01	116
Number of participants with account balances	2020-01-01	53
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	129
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	110
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	13
Total of all active and inactive participants	2019-01-01	123
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	123
Number of participants with account balances	2019-01-01	63
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	142
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	118
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	9
Total of all active and inactive participants	2018-01-01	127
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	127
Number of participants with account balances	2018-01-01	63
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	129
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	133
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	5
Total of all active and inactive participants	2017-01-01	138
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	138
Number of participants with account balances	2017-01-01	64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	128
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	124
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	5
Total of all active and inactive participants	2016-01-01	129
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	129
Number of participants with account balances	2016-01-01	64
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	341
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	338
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	23
Total of all active and inactive participants	2015-01-01	361
Total participants	2015-01-01	361
Number of participants with account balances	2015-01-01	151
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	11
2014: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	316
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	268
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	22
Total of all active and inactive participants	2014-01-01	290
Total participants	2014-01-01	290
Number of participants with account balances	2014-01-01	160
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	6
2013: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	330
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	281
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	15
Total of all active and inactive participants	2013-01-01	296
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	296
Number of participants with account balances	2013-01-01	163
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	1
2012: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	350
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	274
Number of other retired or separated participants entitled to future benefits	2012-01-01	23
Total of all active and inactive participants	2012-01-01	297
Total participants	2012-01-01	297
Number of participants with account balances	2012-01-01	161
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	4
2011: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2011 401k membership
Total participants, beginning-of-year	2011-01-01	296
Total number of active participants reported on line 7a of the Form 5500	2011-01-01	292
Number of other retired or separated participants entitled to future benefits	2011-01-01	31
Total of all active and inactive participants	2011-01-01	323
Total participants	2011-01-01	323
Number of participants with account balances	2011-01-01	171
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2011-01-01	7
2009: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	310
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	267
Number of other retired or separated participants entitled to future benefits	2009-01-01	15
Total of all active and inactive participants	2009-01-01	282
Total participants	2009-01-01	282
Number of participants with account balances	2009-01-01	186
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	12

Financial Data on KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN

Measure	Date	Value
2022 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2022 401k financial data
Total income from all sources (including contributions)	2022-12-31	$-1,182,517
Total of all expenses incurred	2022-12-31	$657,104
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$656,233
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$208,594
Value of total assets at end of year	2022-12-31	$6,113,890
Value of total assets at beginning of year	2022-12-31	$7,953,511
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$871
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$140,111
Total non interest bearing cash at end of year	2022-12-31	$732
Total non interest bearing cash at beginning of year	2022-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-1,839,621
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$6,113,890
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$7,953,511
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Investment advisory and management fees	2022-12-31	$871
Value of interest in pooled separate accounts at end of year	2022-12-31	$6,113,158
Value of interest in pooled separate accounts at beginning of year	2022-12-31	$7,953,511
Net investment gain/loss from pooled separate accounts	2022-12-31	$-1,391,111
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$68,483
Employer contributions (assets) at beginning of year	2022-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$656,233
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2022-12-31	262728289
2021 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2021 401k financial data
Total income from all sources (including contributions)	2021-12-31	$1,030,653
Total of all expenses incurred	2021-12-31	$103,955
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$103,402
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$145,576
Value of total assets at end of year	2021-12-31	$7,953,511
Value of total assets at beginning of year	2021-12-31	$7,026,813
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$553
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$145,576
Total non interest bearing cash at end of year	2021-12-31	$0
Total non interest bearing cash at beginning of year	2021-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$926,698
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$7,953,511
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$7,026,813
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$553
Value of interest in pooled separate accounts at end of year	2021-12-31	$7,953,511
Value of interest in pooled separate accounts at beginning of year	2021-12-31	$7,026,150
Net investment gain/loss from pooled separate accounts	2021-12-31	$885,077
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$0
Employer contributions (assets) at end of year	2021-12-31	$0
Employer contributions (assets) at beginning of year	2021-12-31	$663
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$103,402
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Disclaimer
Accountancy firm name	2021-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2021-12-31	262728289
2020 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2020 401k financial data
Total income from all sources (including contributions)	2020-12-31	$1,587,684
Total of all expenses incurred	2020-12-31	$2,362,647
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,362,095
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$570,367
Value of total assets at end of year	2020-12-31	$7,026,813
Value of total assets at beginning of year	2020-12-31	$7,801,776
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$552
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$165,376
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$404,991
Total non interest bearing cash at end of year	2020-12-31	$0
Total non interest bearing cash at beginning of year	2020-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$-774,963
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$7,026,813
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$7,801,776
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$0
Value of interest in pooled separate accounts at end of year	2020-12-31	$7,026,150
Value of interest in pooled separate accounts at beginning of year	2020-12-31	$7,801,217
Net investment gain/loss from pooled separate accounts	2020-12-31	$1,017,317
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Employer contributions (assets) at end of year	2020-12-31	$663
Employer contributions (assets) at beginning of year	2020-12-31	$559
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,362,095
Contract administrator fees	2020-12-31	$552
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2020-12-31	262728289
2019 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2019 401k financial data
Total income from all sources (including contributions)	2019-12-31	$1,514,587
Total income from all sources (including contributions)	2019-12-31	$1,514,587
Total of all expenses incurred	2019-12-31	$104,391
Total of all expenses incurred	2019-12-31	$104,391
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$104,010
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$104,010
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$270,166
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$270,166
Value of total assets at end of year	2019-12-31	$7,801,776
Value of total assets at end of year	2019-12-31	$7,801,776
Value of total assets at beginning of year	2019-12-31	$6,391,580
Value of total assets at beginning of year	2019-12-31	$6,391,580
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$381
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$381
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$200,644
Contributions received from participants	2019-12-31	$200,644
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$0
Total non interest bearing cash at end of year	2019-12-31	$0
Total non interest bearing cash at end of year	2019-12-31	$0
Total non interest bearing cash at beginning of year	2019-12-31	$22,387
Total non interest bearing cash at beginning of year	2019-12-31	$22,387
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Income. Non cash contributions	2019-12-31	$0
Income. Non cash contributions	2019-12-31	$0
Value of net income/loss	2019-12-31	$1,410,196
Value of net income/loss	2019-12-31	$1,410,196
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$7,801,776
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$7,801,776
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$6,391,580
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$6,391,580
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Investment advisory and management fees	2019-12-31	$0
Investment advisory and management fees	2019-12-31	$0
Value of interest in pooled separate accounts at end of year	2019-12-31	$7,801,217
Value of interest in pooled separate accounts at end of year	2019-12-31	$7,801,217
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$6,366,997
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$6,366,997
Net investment gain/loss from pooled separate accounts	2019-12-31	$1,244,421
Net investment gain/loss from pooled separate accounts	2019-12-31	$1,244,421
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$69,522
Contributions received in cash from employer	2019-12-31	$69,522
Employer contributions (assets) at end of year	2019-12-31	$559
Employer contributions (assets) at end of year	2019-12-31	$559
Employer contributions (assets) at beginning of year	2019-12-31	$2,196
Employer contributions (assets) at beginning of year	2019-12-31	$2,196
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$104,010
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$104,010
Contract administrator fees	2019-12-31	$381
Contract administrator fees	2019-12-31	$381
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm name	2019-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2019-12-31	262728289
Accountancy firm EIN	2019-12-31	262728289
2018 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2018 401k financial data
Total transfer of assets from this plan	2018-12-31	$218
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$-216,800
Total of all expenses incurred	2018-12-31	$420,791
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$420,429
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$294,745
Value of total assets at end of year	2018-12-31	$6,391,580
Value of total assets at beginning of year	2018-12-31	$7,029,389
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$362
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$203,194
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$10,401
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2018-12-31	$0
Total non interest bearing cash at end of year	2018-12-31	$22,387
Total non interest bearing cash at beginning of year	2018-12-31	$36,227
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-637,591
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$6,391,580
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$7,029,389
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in pooled separate accounts at end of year	2018-12-31	$6,366,997
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$6,986,466
Net investment gain/loss from pooled separate accounts	2018-12-31	$-511,545
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$81,150
Employer contributions (assets) at end of year	2018-12-31	$2,196
Employer contributions (assets) at beginning of year	2018-12-31	$6,696
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$420,429
Contract administrator fees	2018-12-31	$362
Liabilities. Value of benefit claims payable at beginning of year	2018-12-31	$0
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2018-12-31	262728289
2017 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2017 401k financial data
Total transfer of assets from this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$7,634
Total income from all sources (including contributions)	2017-12-31	$1,262,768
Total of all expenses incurred	2017-12-31	$976,492
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$976,135
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$271,645
Value of total assets at end of year	2017-12-31	$7,029,389
Value of total assets at beginning of year	2017-12-31	$6,750,747
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$357
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$181,680
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2017-12-31	$5,260
Total non interest bearing cash at end of year	2017-12-31	$36,227
Total non interest bearing cash at beginning of year	2017-12-31	$42,579
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$286,276
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$7,029,389
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$6,743,113
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in pooled separate accounts at end of year	2017-12-31	$6,986,466
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$6,703,832
Net investment gain/loss from pooled separate accounts	2017-12-31	$991,123
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$89,965
Employer contributions (assets) at end of year	2017-12-31	$6,696
Employer contributions (assets) at beginning of year	2017-12-31	$4,336
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$976,135
Contract administrator fees	2017-12-31	$357
Liabilities. Value of benefit claims payable at end of year	2017-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2017-12-31	$2,374
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2017-12-31	262728289
2016 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2016 401k financial data
Total transfer of assets from this plan	2016-12-31	$3,001,968
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$7,634
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$6,259
Total income from all sources (including contributions)	2016-12-31	$443,100
Total of all expenses incurred	2016-12-31	$835,919
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$835,321
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$282,954
Value of total assets at end of year	2016-12-31	$6,750,747
Value of total assets at beginning of year	2016-12-31	$10,144,159
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$598
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$193,743
Participant contributions at beginning of year	2016-12-31	$31
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2016-12-31	$5,260
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2016-12-31	$6,259
Other income not declared elsewhere	2016-12-31	$0
Total non interest bearing cash at end of year	2016-12-31	$42,579
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$-392,819
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$6,743,113
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$10,137,900
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Investment advisory and management fees	2016-12-31	$598
Value of interest in pooled separate accounts at end of year	2016-12-31	$6,703,832
Value of interest in pooled separate accounts at beginning of year	2016-12-31	$10,095,792
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2016-12-31	$34,225
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2016-12-31	$34,225
Net investment gain/loss from pooled separate accounts	2016-12-31	$160,146
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$89,211
Employer contributions (assets) at end of year	2016-12-31	$4,336
Employer contributions (assets) at beginning of year	2016-12-31	$14,111
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$835,321
Liabilities. Value of benefit claims payable at end of year	2016-12-31	$2,374
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	MCCALL SCANLON & TICE, LLC
Accountancy firm EIN	2016-12-31	262728289
2015 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2015 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$6,259
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$1,024
Total income from all sources (including contributions)	2015-12-31	$467,900
Total of all expenses incurred	2015-12-31	$1,070,283
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$1,069,604
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$591,986
Value of total assets at end of year	2015-12-31	$10,144,159
Value of total assets at beginning of year	2015-12-31	$10,741,307
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$679
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$384,432
Participant contributions at end of year	2015-12-31	$31
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$5,663
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2015-12-31	$6,259
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-12-31	$1,024
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$-602,383
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$10,137,900
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$10,740,283
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Investment advisory and management fees	2015-12-31	$679
Value of interest in pooled separate accounts at end of year	2015-12-31	$10,095,792
Value of interest in pooled separate accounts at beginning of year	2015-12-31	$10,728,788
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2015-12-31	$34,225
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2015-12-31	$10,765
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2015-12-31	$10,765
Net investment gain/loss from pooled separate accounts	2015-12-31	$-124,086
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$201,891
Employer contributions (assets) at end of year	2015-12-31	$14,111
Employer contributions (assets) at beginning of year	2015-12-31	$1,754
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$1,069,604
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	SISTERSON & CO. LLP
Accountancy firm EIN	2015-12-31	251467156
2014 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2014 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$1,024
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$1,147
Total income from all sources (including contributions)	2014-12-31	$1,159,036
Total of all expenses incurred	2014-12-31	$244,105
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$244,028
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$659,090
Value of total assets at end of year	2014-12-31	$10,741,307
Value of total assets at beginning of year	2014-12-31	$9,826,499
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$77
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$445,302
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$31,420
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$1,024
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2014-12-31	$1,147
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$914,931
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$10,740,283
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$9,825,352
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in pooled separate accounts at end of year	2014-12-31	$10,728,788
Value of interest in pooled separate accounts at beginning of year	2014-12-31	$9,812,812
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2014-12-31	$10,765
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2014-12-31	$13,687
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2014-12-31	$13,687
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$499,946
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$182,368
Employer contributions (assets) at end of year	2014-12-31	$1,754
Employer contributions (assets) at beginning of year	2014-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$244,028
Contract administrator fees	2014-12-31	$77
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	SISTERSON & CO. LLP
Accountancy firm EIN	2014-12-31	251467156
2013 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2013 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$1,147
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$1,284
Total income from all sources (including contributions)	2013-12-31	$2,234,800
Total of all expenses incurred	2013-12-31	$312,464
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$297,694
Value of total corrective distributions	2013-12-31	$14,096
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$718,072
Value of total assets at end of year	2013-12-31	$9,826,499
Value of total assets at beginning of year	2013-12-31	$7,904,300
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$674
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$461,754
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$71,844
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2013-12-31	$1,147
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2013-12-31	$1,284
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$1,922,336
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$9,825,352
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$7,903,016
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in pooled separate accounts at end of year	2013-12-31	$9,812,812
Value of interest in pooled separate accounts at beginning of year	2013-12-31	$7,887,175
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2013-12-31	$13,687
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2013-12-31	$17,125
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2013-12-31	$17,125
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$1,516,728
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$184,474
Employer contributions (assets) at end of year	2013-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$297,694
Contract administrator fees	2013-12-31	$674
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Liabilities. Value of acquisition indebtedness at beginning of year	2013-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	SISTERSON & CO. LLP
Accountancy firm EIN	2013-12-31	251467156
2012 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2012 401k financial data
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$1,284
Total income from all sources (including contributions)	2012-12-31	$1,527,875
Total of all expenses incurred	2012-12-31	$562,963
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$540,065
Value of total corrective distributions	2012-12-31	$22,281
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$589,744
Value of total assets at end of year	2012-12-31	$7,904,300
Value of total assets at beginning of year	2012-12-31	$6,938,104
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$617
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Administrative expenses professional fees incurred	2012-12-31	$0
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$413,796
Participant contributions at beginning of year	2012-12-31	$14,167
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$6,305
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2012-12-31	$1,284
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$964,912
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$7,903,016
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$6,938,104
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in pooled separate accounts at end of year	2012-12-31	$7,887,175
Value of interest in pooled separate accounts at beginning of year	2012-12-31	$6,915,638
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2012-12-31	$17,125
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$7,337
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$7,337
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$938,131
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$169,643
Employer contributions (assets) at beginning of year	2012-12-31	$962
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$540,065
Contract administrator fees	2012-12-31	$617
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Liabilities. Value of acquisition indebtedness at end of year	2012-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	SISTERSON & CO. LLP
Accountancy firm EIN	2012-12-31	251467156
2011 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2011 401k financial data
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2011-12-31	$0
Total income from all sources (including contributions)	2011-12-31	$452,057
Total of all expenses incurred	2011-12-31	$426,731
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2011-12-31	$425,965
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2011-12-31	$662,337
Value of total assets at end of year	2011-12-31	$6,938,104
Value of total assets at beginning of year	2011-12-31	$6,912,778
Total of administrative expenses incurred including professional, contract, advisory and management fees	2011-12-31	$766
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2011-12-31	No
Administrative expenses professional fees incurred	2011-12-31	$766
Was this plan covered by a fidelity bond	2011-12-31	Yes
Value of fidelity bond cover	2011-12-31	$150,000
If this is an individual account plan, was there a blackout period	2011-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2011-12-31	No
Contributions received from participants	2011-12-31	$434,162
Participant contributions at end of year	2011-12-31	$14,167
Participant contributions at beginning of year	2011-12-31	$14,809
Income. Received or receivable in cash from other sources (including rollovers)	2011-12-31	$51,772
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Value of net income/loss	2011-12-31	$25,326
Value of net assets at end of year (total assets less liabilities)	2011-12-31	$6,938,104
Value of net assets at beginning of year (total assets less liabilities)	2011-12-31	$6,912,778
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2011-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2011-12-31	No
Were any leases to which the plan was party in default or uncollectible	2011-12-31	No
Value of interest in pooled separate accounts at end of year	2011-12-31	$6,915,638
Value of interest in pooled separate accounts at beginning of year	2011-12-31	$6,894,670
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2011-12-31	$7,337
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2011-12-31	$-210,280
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2011-12-31	No
Was there a failure to transmit to the plan any participant contributions	2011-12-31	No
Has the plan failed to provide any benefit when due under the plan	2011-12-31	No
Contributions received in cash from employer	2011-12-31	$176,403
Employer contributions (assets) at end of year	2011-12-31	$962
Employer contributions (assets) at beginning of year	2011-12-31	$3,299
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2011-12-31	$425,965
Did the plan have assets held for investment	2011-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2011-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2011-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2011-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2011-12-31	Disclaimer
Accountancy firm name	2011-12-31	SISTERSON & CO. LLP
Accountancy firm EIN	2011-12-31	251467156
2010 : KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets	2010-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2010-12-31	$0
Total income from all sources (including contributions)	2010-12-31	$1,470,891
Total loss/gain on sale of assets	2010-12-31	$0
Total of all expenses incurred	2010-12-31	$289,019
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2010-12-31	$288,344
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2010-12-31	$693,609
Value of total assets at end of year	2010-12-31	$6,912,778
Value of total assets at beginning of year	2010-12-31	$5,730,906
Total of administrative expenses incurred including professional, contract, advisory and management fees	2010-12-31	$675
Total interest from all sources	2010-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2010-12-31	$0
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2010-12-31	No
Administrative expenses professional fees incurred	2010-12-31	$675
Was this plan covered by a fidelity bond	2010-12-31	Yes
Value of fidelity bond cover	2010-12-31	$150,000
If this is an individual account plan, was there a blackout period	2010-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2010-12-31	No
Contributions received from participants	2010-12-31	$457,078
Participant contributions at end of year	2010-12-31	$14,809
Income. Received or receivable in cash from other sources (including rollovers)	2010-12-31	$41,825
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2010-12-31	$0
Other income not declared elsewhere	2010-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Value of net income/loss	2010-12-31	$1,181,872
Value of net assets at end of year (total assets less liabilities)	2010-12-31	$6,912,778
Value of net assets at beginning of year (total assets less liabilities)	2010-12-31	$5,730,906
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2010-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2010-12-31	No
Were any leases to which the plan was party in default or uncollectible	2010-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2010-12-31	$6,894,670
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2010-12-31	$0
Value of interest in pooled separate accounts at end of year	2010-12-31	$6,894,670
Value of interest in pooled separate accounts at beginning of year	2010-12-31	$5,700,764
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2010-12-31	$0
Net investment gain/loss from pooled separate accounts	2010-12-31	$777,282
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2010-12-31	No
Was there a failure to transmit to the plan any participant contributions	2010-12-31	No
Has the plan failed to provide any benefit when due under the plan	2010-12-31	No
Contributions received in cash from employer	2010-12-31	$194,706
Employer contributions (assets) at end of year	2010-12-31	$3,299
Employer contributions (assets) at beginning of year	2010-12-31	$30,142
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2010-12-31	$288,344
Did the plan have assets held for investment	2010-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2010-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2010-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2010-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2010-12-31	Disclaimer
Accountancy firm name	2010-12-31	SISTERSON & CO. LLP
Accountancy firm EIN	2010-12-31	251467156

Form 5500 Responses for KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN

2022: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Insurance	Yes
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement – Insurance	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	Yes
2021-01-01	Plan funding arrangement – Insurance	Yes
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement – Insurance	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	Yes
2020-01-01	Plan funding arrangement – Insurance	Yes
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement – Insurance	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Insurance	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement – Insurance	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Insurance	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement – Insurance	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Insurance	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement – Insurance	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Insurance	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement – Insurance	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Mulitple employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Insurance	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement – Insurance	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Mulitple employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Insurance	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement – Insurance	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Mulitple employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Insurance	Yes
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement – Insurance	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Mulitple employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Insurance	Yes
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement – Insurance	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2011: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2011 form 5500 responses
2011-01-01	Type of plan entity	Mulitple employer plan
2011-01-01	Submission has been amended	No
2011-01-01	This submission is the final filing	No
2011-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2011-01-01	Plan is a collectively bargained plan	No
2011-01-01	Plan funding arrangement – Insurance	Yes
2011-01-01	Plan funding arrangement – Trust	Yes
2011-01-01	Plan benefit arrangement – Insurance	Yes
2011-01-01	Plan benefit arrangement - Trust	Yes
2009: KLINGENSMITH DRUG, INC. 401(K) PROFIT SHARING PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Insurance	Yes
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement – Insurance	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Insurance Providers Used on plan

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	48
Insurance policy start date	2022-01-01
Insurance policy end date	2022-12-31
Total amount of commissions paid to insurance broker	USD $17,456
Total amount of fees paid to insurance company	USD $4,237
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $17,456
Insurance broker organization code?	4
Amount paid for insurance broker fees	4237
Additional information about fees paid to insurance broker	SERVICE FEES

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	52
Insurance policy start date	2021-01-01
Insurance policy end date	2021-12-31
Total amount of commissions paid to insurance broker	USD $18,895
Total amount of fees paid to insurance company	USD $4,738
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $18,895
Insurance broker organization code?	4
Amount paid for insurance broker fees	4738
Additional information about fees paid to insurance broker	SERVICE FEES

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	61
Insurance policy start date	2020-01-01
Insurance policy end date	2020-12-31
Total amount of commissions paid to insurance broker	USD $17,859
Total amount of fees paid to insurance company	USD $4,406
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $17,859
Insurance broker organization code?	4
Amount paid for insurance broker fees	4406
Additional information about fees paid to insurance broker	SERVICE FEES

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	63
Insurance policy start date	2019-01-01
Insurance policy end date	2019-12-31
Total amount of commissions paid to insurance broker	USD $17,725
Total amount of fees paid to insurance company	USD $4,474
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $17,725
Insurance broker organization code?	4
Amount paid for insurance broker fees	4474
Additional information about fees paid to insurance broker	SERVICE FEES

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	63
Insurance policy start date	2018-01-01
Insurance policy end date	2018-12-31
Total amount of commissions paid to insurance broker	USD $17,858
Total amount of fees paid to insurance company	USD $4,401
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?	No
Commission paid to Insurance Broker	USD $17,858
Insurance broker organization code?	4
Amount paid for insurance broker fees	4401
Additional information about fees paid to insurance broker	SERVICE FEES

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	64
Insurance policy start date	2017-01-01
Insurance policy end date	2017-12-31
Total amount of commissions paid to insurance broker	USD $16,685
Total amount of fees paid to insurance company	USD $4,156
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $16,685
Insurance broker organization code?	4
Amount paid for insurance broker fees	4156
Additional information about fees paid to insurance broker	SERVICE FEES
Insurance broker name	W W ACTUARIAL SERVICES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	148
Insurance policy start date	2015-01-01
Insurance policy end date	2015-12-31
Total amount of commissions paid to insurance broker	USD $27,192
Total amount of fees paid to insurance company	USD $6,716
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $27,192
Insurance broker organization code?	4
Amount paid for insurance broker fees	6716
Additional information about fees paid to insurance broker	SERVICE FEES
Insurance broker name	W W ACTUARIAL SERVICES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Insurance policy start date	2014-01-01
Insurance policy end date	2014-12-31
Total amount of commissions paid to insurance broker	USD $25,885
Total amount of fees paid to insurance company	USD $6,470
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $25,885
Insurance broker organization code?	4
Amount paid for insurance broker fees	6470
Additional information about fees paid to insurance broker	SERVICE FEES
Insurance broker name	W W ACTUARIAL SERVICES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	163
Insurance policy start date	2013-01-01
Insurance policy end date	2013-12-31
Total amount of commissions paid to insurance broker	USD $21,947
Total amount of fees paid to insurance company	USD $5,545
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $21,947
Insurance broker organization code?	4
Amount paid for insurance broker fees	5545
Additional information about fees paid to insurance broker	SERVICE FEES
Insurance broker name	W W ACTUARIAL SERVICES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	161
Insurance policy start date	2012-01-01
Insurance policy end date	2012-12-31
Total amount of commissions paid to insurance broker	USD $18,406
Total amount of fees paid to insurance company	USD $4,667
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $18,406
Insurance broker organization code?	4
Amount paid for insurance broker fees	4667
Additional information about fees paid to insurance broker	SERVICE FEES
Insurance broker name	W W ACTUARIAL SERVICES, INC.

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	178
Insurance policy start date	2011-01-01
Insurance policy end date	2011-12-31
Total amount of commissions paid to insurance broker	USD $17,992
Total amount of fees paid to insurance company	USD $4,466
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes

JOHN HANCOCK LIFE INSURANCE COMPANY (U.S.A.) (National Association of Insurance Commissioners NAIC id number: 65838 )

Policy contract number

91809

Policy instance

Insurance contract or identification number	91809
Number of Individuals Covered	184
Insurance policy start date	2010-01-01
Insurance policy end date	2010-12-31
Total amount of commissions paid to insurance broker	USD $22,706
Total amount of fees paid to insurance company	USD $3,788
Are there contracts with unallocated funds for contracts of type guaranteed investment?	Yes
Commission paid to Insurance Broker	USD $11,341
Insurance broker organization code?	4
Amount paid for insurance broker fees	18152
Additional information about fees paid to insurance broker	SERVICE FEES
Insurance broker name	W W ACTUARIAL SERVICES, INC.

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	KLINGENSMITH DRUG, INC.
Employer identification number (EIN):	251258407
NAIC Classification:	446110
NAIC Description:	Pharmacies and Drug Stores